This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.
Anti-NMDA receptor encephalitis is characterized by dyskinesias, psychosis, and seizures1 secondary to antibodies to the NR1-NR2B heteromer of the NMDA receptor.2 This syndrome, more common in women, is often related to an ovarian tumor1; the prognosis is better if the tumor is identified within 3 months of onset. Our case had nonconvulsive status epilepticus lasting 6 months, with marked improvement following removal of the ovarian tumor.
Case report.
A 35-year-old woman, previously healthy and without history of psychosis, had a 3-week history of progressive headaches, short-term memory loss, and irritability. On admission, she was psychotic, requiring physical and chemical restraints. She was unable to follow commands, had echolalia, and had occasional dystonic posturing of her limbs. One week later, she became unresponsive to external stimuli. An EEG demonstrated persistent nonconvulsive status epilepticus (NCSE). Initial CSF studies were remarkable for a lymphocytic pleocytosis with 386 leukocytes. Brain MRI showed diffusion-weighted imaging hyperintensity in the right medial temporal lobe transitioning to fluid-attenuated inversion recovery hyperintensity on repeat imaging (figure 1A). Tests for multiple viral and bacterial pathogens, including herpes simplex virus, were negative. A paraneoplastic …
AAN Members
We have changed the login procedure to improve access between AAN.com and the Neurology journals. If you are experiencing issues, please log out of AAN.com and clear history and cookies. (For instructions by browser, please click the instruction pages below). After clearing, choose preferred Journal and select login for AAN Members. You will be redirected to a login page where you can log in with your AAN ID number and password. When you are returned to the Journal, your name should appear at the top right of the page.
AAN Non-Member Subscribers
Purchase access
Disputes & Debates: Rapid online correspondence
NOTE: All authors' disclosures must be entered and current in our database before comments can be posted. Enter and update disclosures at http://submit.neurology.org. Exception: replies to comments concerning an article you originally authored do not require updated disclosures.
- Stay timely. Submit only on articles published within the last 8 weeks.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- 200 words maximum.
- 5 references maximum. Reference 1 must be the article on which you are commenting.
- 5 authors maximum. Exception: replies can include all original authors of the article.
- Submitted comments are subject to editing and editor review prior to posting.